Date: Wednesday, April 5, 2017
Time: Noon to 2 p.m. EDT

There’s been a sea change in the political climate. The regulatory forecast is still uncertain, and pharmaceutical evolution continues to develop.

Efforts to extend the life cycle of pharmaceutical products frequently involve innovations and improvements in product design, formulation, route of administration and treatment indications. In addition, negotiation of agreements with competitors, including generic and biosimilar manufacturers, is frequently employed as part of a life cycle management strategy. However, recent changes in patent, regulatory and antitrust laws have introduced considerable complexity and risk into these strategies.

Be prepared for what the next year may bring by attending this important webinar, which brings together our experienced professionals to talk about these issues and approaches for successful pharmaceutical life cycle management.

Presenters:

• Carl W. Hittinger, Partner, Philadelphia
• Lee H. Rosebush, Partner, Washington, D.C.
• Lance L. Shea, Partner, Washington, D.C.
• S. Maurice Valla, Partner, Philadelphia

2.0 hours of CLE credit offered in MD, VA, NY, and NJ. Additional states may be available upon request.

For questions, please contact Natalia Egan at 216.430.2941.

Register now!